Literature DB >> 18462891

Lobular endocervical glandular hyperplasia might become a precursor of adenocarcinoma with pyloric gland features.

Yoshiki Ohta1, Takao Suzuki, Shigeharu Hamatani, Akira Shiokawa, Miki Kushima, Hidekazu Ota.   

Abstract

We report a case of adenocarcinoma with pyloric gland features, which appears to have originated from lobular endocervical glandular hyperplasia (LEGH). Hematoxylin and eosin staining, as well as histochemical and immunohistochemical stainings were performed on formalin-fixed and paraffin-embedded specimens. LEGH was observed in the conization specimens. In the hysterectomy specimens, LEGH, atypical LEGH, and mucinous adenocarcinoma coexisted. The adenocarcinoma was located at a site distant from the transition zone. p16(INK4a) immunopositivity was extremely rare. Front formation was observed, and a transition from benign-looking columnar cells of LEGH to adenocarcinoma was recognized. These findings suggested that the adenocarcinoma with pyloric gland features arose from LEGH. LEGH is no longer regarded as a pseudoneoplastic lesion, and it is necessary to consider that LEGH is able to transform into a precursor lesion and to develop into an adenocarcinoma with pyloric gland features.

Entities:  

Mesh:

Year:  2008        PMID: 18462891     DOI: 10.1016/j.prp.2008.02.009

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  2 in total

1.  Gastric gland mucin-specific O-glycan expression decreases as tumor cells progress from lobular endocervical gland hyperplasia to cervical mucinous carcinoma, gastric type.

Authors:  Kazuhiro Yamanoi; Keiko Ishii; Michihiko Tsukamoto; Shiho Asaka; Jun Nakayama
Journal:  Virchows Arch       Date:  2018-05-29       Impact factor: 4.064

2.  Usefulness of a management protocol for patients with cervical multicystic lesions: A retrospective analysis of 94 cases and the significance of GNAS mutation.

Authors:  Hirofumi Ando; Tsutomu Miyamoto; Hiroyasu Kashima; Akiko Takatsu; Keiko Ishii; Yasunari Fujinaga; Tanri Shiozawa
Journal:  J Obstet Gynaecol Res       Date:  2016-10-08       Impact factor: 1.730

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.